Literature DB >> 16025125

Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization.

Jose A Cancelas1, Andrew W Lee, Rethinasamy Prabhakar, Keith F Stringer, Yi Zheng, David A Williams.   

Abstract

The molecular events that regulate engraftment and mobilization of hematopoietic stem cells and progenitors (HSC/Ps) are still incompletely defined. We have examined the role of the Rho GTPases Rac1 and Rac2 in HSC engraftment and mobilization. Rac1, but not the hematopoietic-specific Rac2, is required for the engraftment phase of hematopoietic reconstitution, because Rac1(-/-) HSCs did not rescue in vivo hematopoiesis after transplantation, but deletion of Rac1 after engraftment did not impair steady-state hematopoiesis. Rac1(-/-) HSC/Ps showed impaired spatial localization to the endosteum but near-normal homing to the medullary cavity in vivo. Interaction with the bone marrow microenvironment in vitro was markedly altered. Whereas post-engraftment deletion of Rac1 alone did not impair hematopoiesis, deficiency of both Rac1 and Rac2 led to massive mobilization of HSCs from the marrow associated with ineffective hematopoiesis and intense selection for Rac-expressing HSCs. This mobilization was reversible by re-expression of Rac1. In addition, a rationally designed, reversible small-molecule inhibitor of Rac activation led to transient mobilization of engraftable HSC/Ps. Rac proteins thus differentially regulate engraftment and mobilization phenotypes, suggesting that these biological processes and steady-state hematopoiesis are biochemically separable and that Rac proteins may be important molecular targets for stem cell modification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025125     DOI: 10.1038/nm1274

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  133 in total

1.  CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin.

Authors:  Maria Verrucci; Alessandro Pancrazzi; Miguel Aracil; Fabrizio Martelli; Paola Guglielmelli; Maria Zingariello; Barbara Ghinassi; Emanuela D'Amore; José Jimeno; Alessandro M Vannucchi; Anna Rita Migliaccio
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 2.  Cancer stem cells: a stride towards cancer cure?

Authors:  Amitava Sengupta; Jose A Cancelas
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 3.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

4.  On how Rac controls hematopoietic stem cell activity.

Authors:  J A Cancelas
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

5.  Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.

Authors:  Steven W Lane; Serena De Vita; Kylie A Alexander; Ruchan Karaman; Michael D Milsom; Adrienne M Dorrance; Amy Purdon; Leeann Louis; Mary L Bouxsein; David A Williams
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

6.  Signaling and cytoskeletal requirements in erythroblast enucleation.

Authors:  Diamantis G Konstantinidis; Suvarnamala Pushkaran; James F Johnson; Jose A Cancelas; Stefanos Manganaris; Chad E Harris; David A Williams; Yi Zheng; Theodosia A Kalfa
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

Review 7.  Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.

Authors:  Aysegul Ocal Sahin; Miranda Buitenhuis
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

Review 8.  Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment.

Authors:  Maria De Grandis; Anne-Catherine Lhoumeau; Stéphane J C Mancini; Michel Aurrand-Lions
Journal:  Cell Mol Life Sci       Date:  2016-02       Impact factor: 9.261

Review 9.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

10.  SHIP is required for a functional hematopoietic stem cell niche.

Authors:  Amy L Hazen; Michelle J Smith; Caroline Desponts; Oliver Winter; Katrin Moser; William G Kerr
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.